Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

April 2022; Volume 42,Issue 4

Reviews

  • Open Access
    Intradural Cauda Equina Metastases: A Systematic Review of Clinico-radiological Features, Management, and Treatment Outcomes
    PAOLO PALMISCIANO, SAIF E. ZAIDI, NATHAN A. SHLOBIN, NAVRAJ S. SAGOO, OTHMAN BIN ALAMER, GIANLUCA SCALIA, GIANLUCA FERINI, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER
    Anticancer Research April 2022, 42 (4) 1661-1669; DOI: https://doi.org/10.21873/anticanres.15643
  • Open Access
    Sun Exposure - Hazards and Benefits
    PELLE G. LINDQVIST, ELISABETH EPSTEIN and MONA LANDIN-OLSSON
    Anticancer Research April 2022, 42 (4) 1671-1677; DOI: https://doi.org/10.21873/anticanres.15644
  • Open Access
    Accuracy of Serum Biomarker Panel (GastroPanel®) in the Diagnosis of Atrophic Gastritis of the Corpus. Systematic Review and Meta-analysis
    KARI SYRJÄNEN
    Anticancer Research April 2022, 42 (4) 1679-1696; DOI: https://doi.org/10.21873/anticanres.15645

Experimental Studies

  • Open Access
    Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth
    JOSEPH L. LASKY, KATHRYN L. BRADFORD, YUNTAO WANG, YOUNGJU PAK and EDUARD H. PANOSYAN
    Anticancer Research April 2022, 42 (4) 1697-1706; DOI: https://doi.org/10.21873/anticanres.15646
  • Open Access
    Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells
    AKIRA ISHIKAWA, KAZUYA KURAOKA, JUNICHI ZAITSU, AKIHISA SAITO, TOSHIO KUWAI, HIROFUMI TAZAWA, TAKAHISA SUZUKI, HIROTAKA TASHIRO, KIYOMI TANIYAMA and WATARU YASUI
    Anticancer Research April 2022, 42 (4) 1707-1717; DOI: https://doi.org/10.21873/anticanres.15647
  • You have access
    Adenovirus Vector With ADP Gene Induces Cytopathic Effects in HEK293 Cells Without Significant Elevation of Virus Titers
    AOI SHIOTA, FUMITAKA NISHIMAE, FUMINORI SAKURAI and HIROYUKI MIZUGUCHI
    Anticancer Research April 2022, 42 (4) 1719-1727; DOI: https://doi.org/10.21873/anticanres.15648
  • Open Access
    Biological Differences Between Ovarian Cancer-associated Fibroblasts and Contralateral Normal Ovary-derived Mesenchymal Stem Cells
    KAZUAKI OHASHI, TAO-SHENG LI, SHOKO MIURA, YURI HASEGAWA and KIYONORI MIURA
    Anticancer Research April 2022, 42 (4) 1729-1737; DOI: https://doi.org/10.21873/anticanres.15649
  • You have access
    Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer
    SALEM ABOBAKER, HAGEN KULBE, ELIANE T. TAUBE, SILVIA DARB-ESFAHANI, ROLF RICHTER, CARSTEN DENKERT, PAUL JANK, JALID SEHOULI and ELENA IOANA BRAICU
    Anticancer Research April 2022, 42 (4) 1739-1747; DOI: https://doi.org/10.21873/anticanres.15650
  • You have access
    Association of Matrix Metallopeptidase-2 Genotypes With Risk of Gastric Cancer in Taiwan
    CHUN-KAI FU, MEI-CHIN MONG, CHIEN-CHIH YU, MEI-DUE YANG, ZHI-HONG WANG, YA-CHEN YANG, JAW-CHYUN CHEN, JEN-SHENG PEI, NING-YI HSIA, CHIA-WEN TSAI, WEN-SHIN CHANG and DA-TIAN BAU
    Anticancer Research April 2022, 42 (4) 1749-1755; DOI: https://doi.org/10.21873/anticanres.15651
  • You have access
    TYRO3 Knockdown Suppresses the Growth of Myeloid Leukaemia Cells
    TATSUYA SAITO, MAI ITOH and SHUJI TOHDA
    Anticancer Research April 2022, 42 (4) 1757-1761; DOI: https://doi.org/10.21873/anticanres.15652
  • You have access
    Integrin α6A (ITGA6A)-type Splice Variant in Extracellular Vesicles Has a Potential as a Novel Marker of the Early Recurrence of Pancreatic Cancer
    TAKASHI ASADA, SHINGO NAKAHATA, YANUAR RAHMAT FAUZI, TOMONAGA ICHIKAWA, KENTARO INOUE, NOBUHIRO SHIBATA, YOSHIRO FUJII, NAOYA IMAMURA, MASAHIDE HIYOSHI, ATSUSHI NANASHIMA and KAZUHIRO MORISHITA
    Anticancer Research April 2022, 42 (4) 1763-1775; DOI: https://doi.org/10.21873/anticanres.15653
  • You have access
    Relationship Between the Structure of Alkylpsoralens and Their Antiproliferative Activity in HL60 Cells
    SATORU KAWAII, YU MATSUOKA, HIDEKI NOGUCHI, TAKANORI SATO and YUKO YOSHIZAWA
    Anticancer Research April 2022, 42 (4) 1777-1783; DOI: https://doi.org/10.21873/anticanres.15654
  • You have access
    Cytotoxic T Cells Activated by Self-differentiated Monocyte-derived Dendritic Cells Against Multiple Myeloma Cells
    WANNASIRI CHIRAPHAPPHAIBOON, PIRIYA LUANGWATTANANUN, AUSSARA PANYA, NIPHAT JIRAPONGWATTANA, PRIMANA PUNNAKITIKASHEM, THAWEESAK CHIEOCHANSIN, MUTITA JUNKING and PA-THAI YENCHITSOMANUS
    Anticancer Research April 2022, 42 (4) 1785-1799; DOI: https://doi.org/10.21873/anticanres.15655
  • You have access
    Poly(Alkyloxyethylene-Lactate Phosphate) for Delivery of Doxorubicin: Synthesis and Characterization
    KANJI YOSHIKAWA, TERUKI NII, KOLIO TROEV, KIMIKO MAKINO and ISSEI TAKEUCHI
    Anticancer Research April 2022, 42 (4) 1801-1811; DOI: https://doi.org/10.21873/anticanres.15656
  • You have access
    CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer
    JUN KI HONG, DO YEON KIM, JAE-SIK SHIN, YEA SEONG RYU, JAI-HEE MOON, DONG-IN KOH, SEUL LEE, JINWOO LEE, WON JUN LEE, EUN YOUNG LEE, SOO-A JUNG, SEUNG CHAN KIM, HA NA YU, MI JIN KIM, SEUNG-WOO HONG, SANG SOO PARK, JOONYEE JUNG, SEUNG MI KIM, EUN HO KIM, HONG-RAE JEONG, JI HEE GONG, JIEUN KIM, TAE WON KIM and DONG-HOON JIN
    Anticancer Research April 2022, 42 (4) 1813-1819; DOI: https://doi.org/10.21873/anticanres.15657
  • Open Access
    Satraplatin Demonstrates High Cytotoxic Activity Against Genetically Defined Lymphoid Malignancies
    THILO ZANDER, JIA XUE, GABRIEL MARKSON, FELIX DAHM and CHRISTOPH RENNER
    Anticancer Research April 2022, 42 (4) 1821-1832; DOI: https://doi.org/10.21873/anticanres.15658
  • You have access
    N-Trans-p-Coumaroyltyramine Enhances Indomethacin- and Diclofenac-induced Apoptosis Through Endoplasmic Reticulum Stress-dependent Mechanism in MCF-7 Cells
    ANGKANA WONGSAKUL, NONTHALERT LERTNITIKUL, RUTT SUTTISRI and SUREE JIANMONGKOL
    Anticancer Research April 2022, 42 (4) 1833-1844; DOI: https://doi.org/10.21873/anticanres.15659

Clinical Studies

  • Open Access
    Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer
    ZACHARY S. MAYO, EVELYN O. ILORI, BRIAN MATIA, TIMOTHY D. SMILE, CHRISTOPHER W. FLEMING, CHANDANA A. REDDY, JOSEPH SCHARPF, ERIC D. LAMARRE, BRANDON L. PRENDES, JAMIE KU, BRIAN B. BURKEY, NIKHIL P. JOSHI, NEIL M. WOODY, SHLOMO A. KOYFMAN and SHAUNA R. CAMPBELL
    Anticancer Research April 2022, 42 (4) 1845-1849; DOI: https://doi.org/10.21873/anticanres.15660
  • Open Access
    Hypofractionated Gamma Knife Radiosurgery: Institutional Experience on Benign and Malignant Intracranial Tumors
    FRANCESCO INSERRA, FABIO BARONE, PAOLO PALMISCIANO, GIANLUCA SCALIA, VALERIO DA ROS, AHMED ABDELSALAM, ANTONIO CREA, MARIA GABRIELLA SABINI, SANTINO O. TOMASI, GIANLUCA FERINI, ROSARIO MAUGERI, LIDIA STRIGARI and GIUSEPPE EMMANUELE UMANA
    Anticancer Research April 2022, 42 (4) 1851-1858; DOI: https://doi.org/10.21873/anticanres.15661
  • You have access
    A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
    AYA KATO, NORIKATSU MIYOSHI, TORU OHTSURU, DAISUKE SAKAI, JUNICHI HASEGAWA, KEN NAKATA, MITSUNOBU IMASATO, TAKESHI KATO, MASAKAZU IKENAGA, TOSHIHIRO KUDO, MITSUYOSHI TEI, YOSHINORI KAGAWA, MAMORU UEMURA, HIDEKAZU TAKAHASHI, TAROH SATOH, MASAKI MORI, TSUNEKAZU MIZUSHIMA, HIROFUMI YAMAMOTO, KOHEI MURATA, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research April 2022, 42 (4) 1859-1865; DOI: https://doi.org/10.21873/anticanres.15662
  • You have access
    The Trend of Combined Modality Treatment and its Outcomes in Elderly Patients With Primary CNS Lymphoma: A 12-year Population-based Analysis Using Propensity Score
    YAZAN SAMHOURI, MOAATH K. MUSTAFA ALI, CYRUS KHAN, RODNEY WEGNER, SEUNG TAE LEE and JOHN LISTER
    Anticancer Research April 2022, 42 (4) 1867-1877; DOI: https://doi.org/10.21873/anticanres.15663
  • Open Access
    The ColonView (CV) Quick Test for Fecal Occult Blood Shows Significantly Higher Diagnostic Accuracy in Detecting Distal than Proximal Colorectal Cancer
    MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARÃES, TUOMAS SELANDER, TAPANI TIUSANEN, KARI SYRJÄNEN and MATTI ESKELINEN
    Anticancer Research April 2022, 42 (4) 1879-1891; DOI: https://doi.org/10.21873/anticanres.15664
  • You have access
    Clinical Utility and Cost of Postoperative Hemoglobin Level Testing Following Robotic-assisted Hysterectomy for Endometrial Cancer
    MASSOUD SHORAKA, SEMIRAMIS L. CARBAJAL-MAMANI, BAHRAM DIDEBAN, ALI ZARRINPAR, CURTIS WARREN, BERNIE AMARO and JOEL CARDENAS-GOICOECHEA
    Anticancer Research April 2022, 42 (4) 1893-1898; DOI: https://doi.org/10.21873/anticanres.15665
  • Open Access
    Diabetes Mellitus and Oral Cancer: A Retrospective Study from Austria
    BERNHARD REMSCHMIDT, MAURO PAU, JAN GAESSLER, WOLFGANG ZEMANN, NORBERT JAKSE, MICHAEL PAYER and DÁNIEL VÉGH
    Anticancer Research April 2022, 42 (4) 1899-1903; DOI: https://doi.org/10.21873/anticanres.15666
  • Open Access
    Clinical Outcomes of Ramucirumab as Post-treatment Following Atezolizumab/Bevacizumab Combination Therapy in Advanced Hepatocellular Carcinoma
    TEIJI KUZUYA, NAOTO KAWABE, SENJU HASHIMOTO, KOHEI FUNASAKA, MITSUO NAGASAKA, YOSHIHITO NAKAGAWA, RYOJI MIYAHARA, TOMOYUKI SHIBATA, TAKESHI TAKAHARA, YUTARO KATO, ATSUSHI SUGIOKA and YOSHIKI HIROOKA
    Anticancer Research April 2022, 42 (4) 1905-1910; DOI: https://doi.org/10.21873/anticanres.15667
  • You have access
    Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy
    MANUEL NEUBERGER, JANINA SKLADNY, NORA GOLY, FREDERIK WESSELS, CHRISTEL WEIß, LUISA EGEN, PHILIPP ERBEN, MATTHIAS GROß-WEEGE, BRITTA GRÜNE, FRIEDRICH HARTUNG, JONAS HERRMANN, PATRICK HONECK, JONAS JARCZYK, KARL-FRIEDRICH KOWALEWSKI, JULIA MÜHLBAUER, KATJA NITSCHKE, MALIN NIENTIEDT, MARGARETE THERESA WALACH, FRANK WALDBILLIG, NIKLAS WESTHOFF, JOST VON HARDENBERG, MAXIMILIAN KRIEGMAIR, THOMAS S. WORST and PHILIPP NUHN
    Anticancer Research April 2022, 42 (4) 1911-1918; DOI: https://doi.org/10.21873/anticanres.15668
  • Open Access
    Diagnostic Impact of Crypt Branching in Patients With Crohn’s Disease: A Validation Study
    CORINNA LANG-SCHWARZ, CARLOS A. RUBIO and MICHAEL VIETH
    Anticancer Research April 2022, 42 (4) 1919-1923; DOI: https://doi.org/10.21873/anticanres.15669
  • You have access
    Improving Breast Conserving Surgery Using the Faxitron® OR Specimen Radiography System – A Complication Analysis, Cost Evaluation and Literature Review
    CHRISTIAN EICHLER, ANKE WESTERHOFF, MATHIAS WARM, BETTINA HANSTEIN, JULIAN PUPPE, BARBARA KRUG and WOLFRAM MALTER
    Anticancer Research April 2022, 42 (4) 1925-1932; DOI: https://doi.org/10.21873/anticanres.15670
  • You have access
    Oncogenic Fusions in Gliomas: An Institutional Experience
    JIRI POLIVKA, MARIAN SVAJDLER, VLADIMIR PRIBAN, JAN MRACEK, PETR KASIK, PETR MARTINEK, NIKOLA PTAKOVA, MAHYAR SHARIF BAGHERI, DATTATRYA SHETTI, MARTIN PESTA, PAVEL POTUZNIK and ONDREJ TOPOLCAN
    Anticancer Research April 2022, 42 (4) 1933-1939; DOI: https://doi.org/10.21873/anticanres.15671
  • You have access
    A Real-world Multicenter Prospective Study of Everolimus in Pancreatic Neuroendocrine Tumors: The ‘PROTOR’ Study
    GREGORY KALTSAS, CHARALAMBOS ANDREADIS, PARASKEVAS KOSMIDIS, DIMITRIOS MAVROUDIS, KALLIOPI PAZAITOU-PANAYIOTOU, MICHAIL VASLAMATZIS and ILIAS ATHANASIADIS
    Anticancer Research April 2022, 42 (4) 1941-1948; DOI: https://doi.org/10.21873/anticanres.15672
  • You have access
    Impact of Modern Management Strategies on the Clinical Outcome of Patients With Low Rectal Cancer – A Retrospective, Monocentric Cohort Study
    ELIAS KARAM, REMY SINDAYIGAYA, URS GIGER-PABST, MICHEL GABRIEL, NICOLAS MICHOT, LISE COURTOT, NICOLAS TABCHOURI, DRIFFA MOUSSATA, THIERRY LECOMTE, SOPHIE CHAPET, GILLES CALAIS, PASCAL BOURLIER, EPHREM SALAMÉ and MEHDI OUAISSI
    Anticancer Research April 2022, 42 (4) 1949-1963; DOI: https://doi.org/10.21873/anticanres.15673
  • You have access
    Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma
    CONCETTA LALISCIA, FEDERICA GENOVESI-EBERT, FRANCO PERRONE, FRANCESCA GUIDO, FEDERICA CRESTI, TAIUSHA FUENTES, NATALINA COCCIA, ROBERTO MATTIONI, RICCARDO MORGANTI and FABIOLA PAIAR
    Anticancer Research April 2022, 42 (4) 1965-1972; DOI: https://doi.org/10.21873/anticanres.15674
  • You have access
    Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer
    DIRK RADES, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and ELISA M. WERNER
    Anticancer Research April 2022, 42 (4) 1973-1977; DOI: https://doi.org/10.21873/anticanres.15675
  • You have access
    Lactate Is a Reliable Predictor of ICU Length of Stay Following Ultra-radical Ovarian Cancer Surgery
    SUSAN ADDLEY, MARK MCGOWAN, VIREN ASHER, ANISH BALI, SUMMI ABDUL, VICTORIA CULLIMORE, HARRIET CROSSLAND and ANDREW PHILLIPS
    Anticancer Research April 2022, 42 (4) 1979-1986; DOI: https://doi.org/10.21873/anticanres.15676
  • You have access
    Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?
    MARTIN SVATON, MONIKA BRATOVA, LEONA KOUBKOVA, ONDREJ FISCHER, BOHUSLAV MELICHAR, MICHAL HRNCIARIK, DANIEL DOLEZAL, ONDREJ BILEK, JANA KREJCI, MARIE DROSSLEROVA, ZDENKA DLOUHA, JIRI BLAZEK, PETRA MAJKOVA, LUCIE BROZOVA and MAREK STASTNY
    Anticancer Research April 2022, 42 (4) 1987-1995; DOI: https://doi.org/10.21873/anticanres.15677
  • You have access
    Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases
    KOICHI TOMITA, NAOKAZU CHIBA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TOSHIMICHI KOBAYASHI, TORU SANO, EIJI HIDAKA and SHIGEYUKI KAWACHI
    Anticancer Research April 2022, 42 (4) 1997-2001; DOI: https://doi.org/10.21873/anticanres.15678
  • You have access
    Differences in Patterns of Recurrence Between Primary and Interval Debulking Surgery for Advanced Ovarian Cancer
    VASILEIOS MITSOPOULOS, ANNI INNAMAA, JONATHAN LIPPIATT, SARAH COLLINS and IOANNIS BILIATIS
    Anticancer Research April 2022, 42 (4) 2003-2008; DOI: https://doi.org/10.21873/anticanres.15679
  • Open Access
    Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial
    TAKASHI YOSHIOKA, MASANOBU TAKAHASHI, YASUHIRO SAKAMOTO, AKIRA OKITA, TADAHISA FUKUI, YASUKO MURAKAWA, YOSHIAKI SHINDO, HIROO IMAI, HISATSUGU OHORI, HIDEKAZU SHIROTA, NATSUKO CHIBA, YURIKO (ITO) SASAHARA, TAKASHI NOMURA, NORIMASA FUKUSHIMA, TAKUHIRO YAMAGUCHI, HIDEKI SHIMODAIRA and CHIKASHI ISHIOKA
    Anticancer Research April 2022, 42 (4) 2009-2015; DOI: https://doi.org/10.21873/anticanres.15680
  • You have access
    Response to Chemotherapy and Clinical Outcome of Patients With Recurrent Epithelial Ovarian Cancer After PARP Inhibitor Maintenance Treatment: A Multicenter Retrospective Italian Study
    ANGIOLO GADDUCCI, STEFANIA COSIO, FABIO LANDONI, ANDREA ALBERTO LISSONI, PAOLO ZOLA, MARIA ELENA LAUDANI, ANTONIO ARDIZZOIA, ANGELA GAMBINO and ENRICO SARTORI
    Anticancer Research April 2022, 42 (4) 2017-2022; DOI: https://doi.org/10.21873/anticanres.15681
  • You have access
    Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events
    MICHIE KATSUTA, TAKAHIRO KIMURA, KOJIRO TASHIRO, MASAYA MURAKAMI, KENICHI HATA, TAKAFUMI YANAGISAWA, HAJIME ONUMA, TOSHIHIRO YAMAMOTO, SHINGO SUGAYA, YOSHINORI WATANABE, YOSHIMASA NOBEYAMA, SHIN EGAWA and AKIHIKO ASAHINA
    Anticancer Research April 2022, 42 (4) 2023-2028; DOI: https://doi.org/10.21873/anticanres.15682
  • You have access
    A Prognostic Tool to Estimate the Risk of Pneumonitis in Patients Irradiated for Lung Cancer
    ESTHER GLATZEL, ELISA M. WERNER, SABINE BOHNET and DIRK RADES
    Anticancer Research April 2022, 42 (4) 2029-2032; DOI: https://doi.org/10.21873/anticanres.15683
  • You have access
    CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer
    YUICHI TACHIKAWA, KAZUSHIGE KAWAI, KOSUKE OZAKI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, JUNKO KISHIKAWA, YUICHIRO YOKOYAMA, SHINYA ABE, YUZO NAGAI, HIROYUKI ANZAI, HIROFUMI SONODA and SOICHIRO ISHIHARA
    Anticancer Research April 2022, 42 (4) 2033-2043; DOI: https://doi.org/10.21873/anticanres.15684
  • You have access
    Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer
    MOTOHIRO FUJIWARA, RYO FUJIWARA, TETSUYA URASAKI, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA
    Anticancer Research April 2022, 42 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.15685
  • You have access
    Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
    MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI and ICHIRO IEIRI
    Anticancer Research April 2022, 42 (4) 2053-2060; DOI: https://doi.org/10.21873/anticanres.15686
  • You have access
    The Significance of CD109 Expression in Oropharyngeal Squamous Cell Carcinoma
    SHOHEI TSUTSUMI, KAHO MOMIYAMA, MASAAKI ICHINOE, TAKUYA KATO, SACHIYO MOGI, SHUNSUKE MIYAMOTO, YOSHIKI MURAKUMO and TAKU YAMASHITA
    Anticancer Research April 2022, 42 (4) 2061-2070; DOI: https://doi.org/10.21873/anticanres.15687
  • You have access
    Elevated Preoperative DUPAN-2 Level Predicts Locoregional Recurrence After Pancreatectomy in Patients With Pancreatic Ductal Adenocarcinoma
    ATSUSHI SASAKI, SHOICHI INOKUCHI, SATOSHI TSUTSUMI, TAKURO FUTSUKAICHI, TAKAHIRO TERASHI, MASAHIKO IKEBE, TOSHIO BANDOH and TOHRU UTSUNOMIYA
    Anticancer Research April 2022, 42 (4) 2071-2078; DOI: https://doi.org/10.21873/anticanres.15688
  • You have access
    Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence
    MASUMI TANAKA, SHIN-ICHI YAMASHITA, YASUTERU YOSHINAGA, YASUKO ENOMOTO, YUKI NOHARA, SYUKO ONO, KAZUKI NABESHIMA, AKINORI IWASAKI and TOSHIHIKO SATO
    Anticancer Research April 2022, 42 (4) 2079-2085; DOI: https://doi.org/10.21873/anticanres.15689
  • You have access
    Combined Use of Calcium-channel Blockers With Ombitasvir/Paritaprevir/Ritonavir Exacerbates Peripheral Edema in Elderly Japanese Patients
    YUNA SADAKA, MIDORI SODA, AKIYO HORI, YURI MIYAHARA, YASUHISA OIDA, YOICHI NISHIGAKI, EIICHI TOMITA, TAKASHI MIZUI and KIYOYUKI KITAICHI
    Anticancer Research April 2022, 42 (4) 2087-2093; DOI: https://doi.org/10.21873/anticanres.15690
  • Open Access
    Clinical Outcomes of Radiotherapy in Elderly and Younger Patients With T4 Esophageal Cancer: A Retrospective Single-center Analysis
    YOSUKE TAKAKUSAGI, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, HIROYUKI KATOH, TADASHI KAMADA, RISA TANIUCHI, MISAKI IINO, TOMOMI AOSHIKA, SATOSHI SAITO and DAISAKU YOSHIDA
    Anticancer Research April 2022, 42 (4) 2095-2104; DOI: https://doi.org/10.21873/anticanres.15691
  • You have access
    Influence of the Coronavirus Disease 2019 Vaccine on Drug Therapy for Urological Cancer
    SHOHEI KAWAGUCHI, KOUJI IZUMI, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, MASASHI IIJIMA, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research April 2022, 42 (4) 2105-2111; DOI: https://doi.org/10.21873/anticanres.15692
  • You have access
    Predictors of Lateral Pelvic Lymph Node Metastasis in Advanced Low Rectal Cancer Treated With Neoadjuvant Chemotherapy
    TETSUO ISHIZAKI, KENJI KATSUMATA, MASANOBU ENOMOTO, JUNICHI MAZAKI, RYUTARO UDO, TOMOYA TAGO, KENTA KASAHARA, HIROSHI KUWABARA, YUICHI NAGAKAWA and AKIHIKO TSUCHIDA
    Anticancer Research April 2022, 42 (4) 2113-2121; DOI: https://doi.org/10.21873/anticanres.15693
  • You have access
    Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy
    MOTOHIRO FUJIWARA, RYO FUJIWARA, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA
    Anticancer Research April 2022, 42 (4) 2123-2130; DOI: https://doi.org/10.21873/anticanres.15694
  • You have access
    Significance of Altered Fatty Acid Transporter Expressions in Uterine Cervical Cancer and Its Precursor Lesions
    JUNGSUK AN, HWA EUN OH, HYESUN KIM, JU-HAN LEE, EUNG SEOK LEE, YOUNG-SIK KIM and JUNG-WOO CHOI
    Anticancer Research April 2022, 42 (4) 2131-2137; DOI: https://doi.org/10.21873/anticanres.15695
  • You have access
    Clavicula Pro Humero Reconstruction for Malignant Tumor of the Proximal Humerus in Children and Adults
    HIDEYUKI KINOSHITA, HIROTO KAMODA, YOKO HAGIWARA, TAKESHI ISHII, SEIJI OHTORI and TSUKASA YONEMOTO
    Anticancer Research April 2022, 42 (4) 2139-2144; DOI: https://doi.org/10.21873/anticanres.15696
  • Open Access
    Real-world Afatinib Outcomes in Advanced Non–small Cell Lung Cancer Harboring EGFR Mutations
    CHI-HAN CHEN, JOHN WEN-CHENG CHANG, CHING-FU CHANG, CHEN-YANG HUANG, CHENG-TA YANG, CHIH-HSI SCOTT KUO, YUEH-FU FANG, PING-CHIH HSU and CHIAO-EN WU
    Anticancer Research April 2022, 42 (4) 2145-2157; DOI: https://doi.org/10.21873/anticanres.15697
  • You have access
    Additional Excision Biopsy in Patients With Atypical Ductal Hyperplasia at Ultrasound-guided Vacuum-assisted Breast Biopsy
    HAI LIN PARK, BORA YANG, JI EUN SHIN, JI-YOUNG KIM, JEONG YUN SHIN, EUNAH SHIN, SONGMI NOH and JAE HONG KIM
    Anticancer Research April 2022, 42 (4) 2159-2165; DOI: https://doi.org/10.21873/anticanres.15698
  • You have access
    Treatment Outcomes in Neuroendocrine Prostate Cancer
    HIROAKI IWAMOTO, RYUNOSUKE NAKAGAWA, TOMOYUKI MAKINO, SUGURU KADOMOTO, HIROSHI YAEGASHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research April 2022, 42 (4) 2167-2176; DOI: https://doi.org/10.21873/anticanres.15699
  • You have access
    The Significance of Surgical Intervention for Metasynchronous Liver Metastasis in Gastric Cancer: A Single-centre Analysis
    TAKEHIKO HANAKI, TEPPEI SUNAGUCHI, KEISUKE GOTO, MASAKI MORIMOTO, YUKI MURAKAMI, YUJI SHISHIDO, KOZO MIYATANI, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, MANABU YAMAMOTO, NARUO TOKUYASU, TERUHISA SAKAMOTO, TOSHIMICHI HASEGAWA and YOSHIYUKI FUJIWARA
    Anticancer Research April 2022, 42 (4) 2177-2184; DOI: https://doi.org/10.21873/anticanres.15700
  • You have access
    Tumor Size Significantly Affects Prognosis in Pathological T3a Renal Cell Carcinoma
    GU-SHUN LAI, JIAN-RI LI, SHIAN-SHIANG WANG, CHUAN-SHU CHEN, CHUN-KUANG YANG, SHENG-CHUN HUNG, CHEN-LI CHENG, YEN-CHUAN OU and KUN-YUAN CHIU
    Anticancer Research April 2022, 42 (4) 2185-2191; DOI: https://doi.org/10.21873/anticanres.15701

ABSTRACTS OF THE JOINT INTERNATIONAL SYMPOSIA “VITAMIN D IN PREVENTION AND THERAPY” AND “BIOLOGIC EFFECTS OF LIGHT”

  • You have access
    ABSTRACTS OF THE JOINT INTERNATIONAL SYMPOSIA “VITAMIN D IN PREVENTION AND THERAPY” AND “BIOLOGIC EFFECTS OF LIGHT”
    J. REICHRATH, TH. VOGT, M.F. HOLICK and M. FRIEDRICH
    Anticancer Research April 2022, 42 (4) 2193-2222; DOI: https://doi.org/10.21873/anticanres.15702

Corrigendum

  • You have access
    Corrigendum
    Anticancer Research April 2022, 42 (4) 2223;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (4)
Anticancer Research
Vol. 42, Issue 4
April 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth
  • Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells
  • Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer
  • Hypofractionated Gamma Knife Radiosurgery: Institutional Experience on Benign and Malignant Intracranial Tumors
  • Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • ABSTRACTS OF THE JOINT INTERNATIONAL SYMPOSIA “VITAMIN D IN PREVENTION AND THERAPY” AND “BIOLOGIC EFFECTS OF LIGHT”
  • Corrigendum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire